Altman Peter
President and CEO, Director
7 filings on record here, covering BCDA. Amounts are the ranges the filer reported, which is how the law requires them to be disclosed.
Filings
CORPORATEFiled 2026-08-13
| Buy | BCDA | BioCardia, Inc. | $1,748 |
CORPORATEFiled 2026-07-29
| Buy | BCDA | BioCardia, Inc. | $3,900 |
CORPORATEFiled 2026-07-10
| Buy | BCDA | BioCardia, Inc. | $5,335 |
| Buy | BCDA | BioCardia, Inc. | $900 |
| Buy | BCDA | BioCardia, Inc. | $940 |
CORPORATEFiled 2026-07-08
| Buy | BCDA | BioCardia, Inc. | $5,208 |
CORPORATEFiled 2026-07-07
| Tax | BCDA | BioCardia, Inc. | $67,711 |
| Award | BCDA | BioCardia, Inc. | |
CORPORATEFiled 2026-07-01
| Award | BCDA | BioCardia, Inc. | $132,750 |
CORPORATEFiled 2026-06-22
| Buy | BCDA | BioCardia, Inc. | $1,275 |
| Buy | BCDA | BioCardia, Inc. | $768 |
Source records are public filings: House and Senate periodic
transaction reports, Office of Government Ethics filings, and SEC Form 4 filings. Amounts
are reported as ranges by law, not exact figures, and filings arrive on a legal delay.
Eltrove reports what was filed. Nothing here is investment advice or a recommendation.